Ultragenyx Pharmaceutical, Inc. (RARE)
23.88
-0.82
(-3.32%)
USD |
NASDAQ |
Feb 09, 16:00
23.80
-0.08
(-0.34%)
After-Hours: 20:00
Ultragenyx Pharmaceutical EPS Diluted (Quarterly) : -1.808 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Johnson & Johnson | 2.098 |
| CorMedix, Inc. | 1.259 |
| Insmed, Inc. | -1.747 |
| Apellis Pharmaceuticals, Inc. | 1.658 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -180.41M |
| Revenue (Quarterly) | 159.93M |
| Total Expenses (Quarterly) | 340.35M |
| Enterprise Value | 2.739B |
| Gross Profit Margin (Quarterly) | 77.12% |
| Profit Margin (Quarterly) | -112.8% |
| Earnings Yield | -24.87% |
| Normalized Earnings Yield | -24.84 |